Evidence map›Paper›PMID 37902675›Full record

ReviewEnvironmental health perspectives2023

Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned.

Michelle C Turner, Vincent Cogliano, Kathryn Guyton, Federica Madia, Kurt Straif, Elizabeth M Ward, Mary K Schubauer-Berigan

Open access · diamondAbstract readReview
In one paragraph

Review in Environmental health perspectives, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Five decades of occupational cancer epidemiology.Scandinavian journal of work, environment & health · 2024
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Michelle C TurnerBarcelona Institute for Global Health, Barcelona, Spain.ORCID 0000-0002-6431-1997
Vincent CoglianoCalifornia Environmental Protection Agency Office of Environmental Health Hazard Assessment, Oakland, California, USA.
Kathryn GuytonNational Academies of Sciences, Engineering, and Medicine, Washington, District of Columbia, USA.
Federica MadiaInternational Agency for Research on Cancer, Lyon, France.
Kurt StraifBarcelona Institute for Global Health, Barcelona, Spain.
Elizabeth M WardAmerican Cancer Society (retired), Atlanta, Georgia, USA.
Mary K Schubauer-BeriganInternational Agency for Research on Cancer, Lyon, France.
Centre international de recherche sur le cancer · FRAmerican Cancer Society · USBoston College · USCalifornia Environmental Protection Agency · USNational Academies of Sciences, Engineering, and Medicine · USUniversitat Pompeu Fabra · ES

Funding

EVALUATION OF CARCINOGENIC RISKS TO HUMANSU01CA033193 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI SCHUBAUER-BERIGAN, MARY K. · 1985 to 2020
$16.5M
NCI NIH HHS U01 CA033193World Health Organization 001
6 · The paper itself

Abstract

backgroundThe International Agency for Research on Cancer (IARC) Monographs program assembles expert working groups who publish a critical review and evaluation of data on agents of interest. These comprehensive reviews provide a unique opportunity to identify research needs to address classification uncertainties. A multidisciplinary expert review and workshop held in 2009 identified research gaps and needs for 20 priority occupational chemicals, metals, dusts, and physical agents, with the goal of stimulating advances in epidemiological studies of cancer and carcinogen mechanisms. Overarching issues were also described.

objectivesIn this commentary we review the current status of the evidence for the 20 priority agents identified in 2009. We examine whether identified Research Recommendations for each agent were addressed and their potential impact on resolving classification uncertainties.

methodsWe reviewed the IARC classifications of each of the 20 priority agents and identified major new epidemiological and human mechanistic studies published since the last evaluation. Information sources were either the published Monograph for agents that have been reevaluated or, for agents not yet reevaluated, Advisory Group reports and literature searches. Findings are described in view of recent methodological developments in Monographs evidence evaluation processes. DISCUSSION: The majority of the 20 priority agents were reevaluated by IARC since 2009. The overall carcinogen classifications of 9 agents advanced, and new cancer sites with either "sufficient" or "limited" evidence of carcinogenicity were also identified for 9 agents. Examination of published findings revealed whether evidence gaps and Research Recommendations have been addressed and highlighted remaining uncertainties. During the past decade, new research addressed a range of the 2009 recommendations and supported updated classifications for priority agents. This supports future efforts to systematically apply findings of Monograph reviews to identify research gaps and priorities relevant to evaluation criteria established in the updated IARC Monograph Preamble. https://doi.org/10.1289/EHP12547.

Indexed as

BiologyNeoplasmsCarcinogensDustEvidence GapsHumansCarcinogensDust

Identifiers

PMID37902675
PMCPMC10615125
OpenAlexW4388034681

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.